Moreover, the oncogenic value of CDH3 is reinforced by the upregulation of CDH3‐positively correlated genes upon knockdown of RB and PTEN tumor‐suppressor genes, and by the association with HOXA9, a transcription factor with critical oncogenic functions in GBM [22, 62, 63]. This evidence concerns the gene CDH3 and neoplasm.